• Users Online: 293
  • Print this page
  • Email this page

Current Issue

January-March 2019| Vol 2| Issue 1

Editorial

Glioma special issue introduction

In the past decade, cancer immunotherapy has emerged from experimental protocols in select pathologies to a mainstay of frontline cancer therapy that has drastically improved outcomes for thousands of...


Review

Importance of iatrogenic immunosuppression in the treatment of patients with high-grade glioma with immunotherapy

Treatment-related lymphopenia is a poor prognostic factor for overall survival in patients with high-grade glioma and predicts suboptimal response to immune therapies. Immunotherapy is conceptually an...


Review

Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma

Glioblastoma is associated with poor prognosis with a mean survival of 15 months after diagnosis. The current standard of care includes surgery, radiation, and temozolomide with the use of tumor-treat...


Review

Immune checkpoint modulation: Tenets and implications in glioblastoma

Glioblastoma (GBM) is the most common primary central nervous system tumor, and despite advances made in traditional chemotherapy and radiation, it continues to carry a poor prognosis. The discovery...


Review

Gamma-delta T cells in glioblastoma immunotherapy

Conventional immunotherapy in the treatment of glioblastoma (GBM) has essentially produced no significant advantage over the use of chemotherapeutic drugs. A strongly immunosuppressive tumor microenvi...


View All Articles in the Current Issue

Glioma, a publication of Chinese Society of Neuro-Oncology (CSNO), is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ